Phase 2 study of preoperative radiation with concurrent capecitabine, oxaliplatin, and bevacizumab followed by surgery and postoperative 5-fluorouracil, leucovorin, oxaliplatin (FOLFOX), and bevacizumab in patients with locally advanced rectal cancer: ECOG 3204

  • Jerome C. Landry
  • , Yang Feng
  • , Steven J. Cohen
  • , Charles A. Staley
  • , Richard Whittington
  • , Elin Ruth Sigurdson
  • , Halla Nimeiri
  • , Udit Verma
  • , Roshan S. Prabhu
  • , Al Bowen Benson

Research output: Contribution to journal › Article › peer-review

50 Scopus citations

Fingerprint

Dive into the research topics of 'Phase 2 study of preoperative radiation with concurrent capecitabine, oxaliplatin, and bevacizumab followed by surgery and postoperative 5-fluorouracil, leucovorin, oxaliplatin (FOLFOX), and bevacizumab in patients with locally advanced rectal cancer: ECOG 3204'. Together they form a unique fingerprint.

Medicine and Dentistry